These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 36628248)
1. Characterization of ligamentum flavum hypertrophy based on m6A RNA methylation modification and the immune microenvironment. He Z; Zhu Z; Tang T; Guo P; Gao M; Li B; Nguyen TCT; Chen H; Liu X; Zhou Z; Liu S Am J Transl Res; 2022; 14(12):8800-8827. PubMed ID: 36628248 [TBL] [Abstract][Full Text] [Related]
2. Revealing the novel autophagy-related genes for ligamentum flavum hypertrophy in patients and mice model. Li P; Fei CS; Chen YL; Chen ZS; Lai ZM; Tan RQ; Yu YP; Xiang X; Dong JL; Zhang JX; Wang L; Zhang ZM Front Immunol; 2022; 13():973799. PubMed ID: 36275675 [TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
4. Immune cell infiltration and the genes associated with ligamentum flavum hypertrophy: Identification and validation. Duan Y; Ni S; Zhao K; Qian J; Hu X Front Cell Dev Biol; 2022; 10():914781. PubMed ID: 36036007 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analyses of m6A RNA methylation patterns and related immune microenvironment in idiopathic pulmonary arterial hypertension. Gao G; Chen A; Gong J; Lin W; Wu W; Mohammad Ismail Hajary S; Lian G; Luo L; Xie L Front Genet; 2023; 14():1222368. PubMed ID: 37732317 [TBL] [Abstract][Full Text] [Related]
6. The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy. Zou R; Liu Y; Qiu S; Lu Y; Chen Y; Yu H; Zhu H; Zhu W; Zhu L; Feng J; Han J Cancer Biomark; 2023; 38(4):551-566. PubMed ID: 38007640 [TBL] [Abstract][Full Text] [Related]
7. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of coronary heart disease. Li Z; Song Y; Wang M; Shen R; Qin K; Zhang Y; Jiang T; Chi Y Front Cardiovasc Med; 2022; 9():905737. PubMed ID: 36093132 [TBL] [Abstract][Full Text] [Related]
8. ADAM10 promotes the proliferation of ligamentum flavum cells by activating the PI3K/AKT pathway. Pan B; Huo T; Cao M; Jing L; Luo X; Qu Z; Feng H; Yuan F; Guo K Int J Mol Med; 2021 Feb; 47(2):688-698. PubMed ID: 33416124 [TBL] [Abstract][Full Text] [Related]
9. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma. Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K Front Immunol; 2021; 12():637933. PubMed ID: 33746977 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183 [TBL] [Abstract][Full Text] [Related]
11. Molecular subtype identification and predictive power of N6-methyladenosine regulator in unexplained recurrent pregnancy loss. Huo J; Chen Q; Zhang Y; Li N; Fu Z; Ma N; Zheng N; Cui N; Li L Front Genet; 2022; 13():925652. PubMed ID: 36118846 [TBL] [Abstract][Full Text] [Related]
12. Novel insight into m6A regulator-mediated methylation modification patterns and immune characteristics in intracranial aneurysm. Li S; Zhang Q; Weng L; Han Y; Li J Front Aging Neurosci; 2022; 14():973258. PubMed ID: 36034129 [TBL] [Abstract][Full Text] [Related]
13. Deciphering Obesity-Related Gene Clusters Unearths SOCS3 Immune Infiltrates and 5mC/m6A Modifiers in Ossification of Ligamentum Flavum Pathogenesis. Zhang B; Yuan L; Chen G; Chen X; Yang X; Fan T; Sun C; Fan D; Chen Z Front Endocrinol (Lausanne); 2022; 13():861567. PubMed ID: 35712246 [TBL] [Abstract][Full Text] [Related]
14. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment. Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
16. RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer. Mu LX; Shao YC; Wei L; Chen FF; Zhang JW Front Genet; 2021; 12():650499. PubMed ID: 35095993 [No Abstract] [Full Text] [Related]
17. m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in patients with intracranial aneurysms. Maimaiti A; Turhon M; Cheng X; Su R; Kadeer K; Axier A; Ailaiti D; Aili Y; Abudusalamu R; Kuerban A; Wang Z; Aisha M Front Neurol; 2022; 13():889141. PubMed ID: 35989938 [TBL] [Abstract][Full Text] [Related]
18. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma. Meijing Z; Tianhang L; Biao Y Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200 [No Abstract] [Full Text] [Related]
19. Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy. Wang Y; Sun N; He R; Wang Z; Jin J; Gao T; Qu J Clin Exp Med; 2024 May; 24(1):92. PubMed ID: 38693353 [TBL] [Abstract][Full Text] [Related]
20. A bioinformatics analysis of the contribution of m6A methylation to the occurrence of diabetes mellitus. Lei L; Bai YH; Jiang HY; He T; Li M; Wang JP Endocr Connect; 2021 Oct; 10(10):1253-1265. PubMed ID: 34486983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]